Strides Pharma Science’s step-down wholly owned subsidiary — Strides Pharma Global Pte, Singapore has entered into an exclusive product development, licensing and supply agreement with SUDA Pharmaceuticals for its novel drug SUD-001H, an oral spray of sumatriptan to treat migraine headache for the US market. Execution of Strides’ generic product pipeline for the US is … Read more
Strides Pharma Science’s step‐down wholly owned subsidiary, Strides Pharma Global Pte, has received approval for Gabapentin Capsules USP, 100 mg, 300 mg, and 400 mg from the United States Food and Drug Administration (USFDA). Gabapentin Capsules is a generic version of Neurontin Capsules of Pfizer. The product received approval in the first cycle of review … Read more
Strides Shasun has received an approval for the Scheme of Amalgamation for the merger of its wholly owned subsidiaries (WOSs) viz., Arrow Remedies, Fagris Medica and Strides Chemicals, with itself. The Board of Directors of the company at their meeting held on October 31, 2017, considered and approved the same. The merger is expected to … Read more
